Literature DB >> 740052

Release of 15-keto-13, 14-dihydro-thromboxane B2 and prostaglandin D2 during anaphylaxis as measured by radioimmunoassay.

H Anhut, B A Peskar, W Bernauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 740052     DOI: 10.1007/bf00498818

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  42 in total

1.  Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin.

Authors:  M Hamberg; B B Fredholm
Journal:  Biochim Biophys Acta       Date:  1976-04-22

2.  The biological significance of prostaglandin-like substances released from immunologically challenged guinea-pig lungs [proceedings].

Authors:  J R Boot; W Dawson; D J Osborne
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

3.  Differential synthesis and metabolism of prostaglandins and thromboxanes released from normal and sensitized guinea-pig lungs [proceedings].

Authors:  J R Boot; A F Cockerill; W Dawson; D N Mallen; D J Osborne
Journal:  J Physiol       Date:  1977-07       Impact factor: 5.182

4.  Prostaglandin D2 inhibits the aggregation of human platelets.

Authors:  J B Smith; M J Silver; C M Ingerman; J J Kocsis
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

Review 5.  Prostaglandins.

Authors:  B Samuelsson; E Granström; K Green; M Hamberg; S Hammarström
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

6.  Contractile effects of a PGH2 analog and PGD2 on intrapulmonary vessels.

Authors:  C A Gruetter; D B McNamara; A L Hyman; P J Kadowitz
Journal:  Am J Physiol       Date:  1978-02

7.  Thromboxane A2 and prostaglandin H2: potent stimulators of the swine coronary artery.

Authors:  J Svensson; M Hamberg
Journal:  Prostaglandins       Date:  1976-12

8.  Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification.

Authors:  R Liebig; W Bernauer; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

10.  Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog.

Authors:  M A Wasserman; D W DuCharme; R L Griffin; G L DeGraaf; F G Robinson
Journal:  Prostaglandins       Date:  1977-02
View more
  6 in total

1.  Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma.

Authors:  J A Schmidt; F M Bell; E Akam; C Marshall; I A Dainty; A Heinemann; I G Dougall; R V Bonnert; C A Sargent
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

2.  Prostaglandin D2 is the prevailing prostaglandin in the acute inflammatory exudate of urate arthritis in the chicken.

Authors:  H Anhut; K Brune; J C Frölich; B A Peskar
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

3.  Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung.

Authors:  J R Hoult; C Robinson
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

4.  The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts.

Authors:  L G Letts; P J Piper
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

5.  Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.

Authors:  Sonia Philipose; Viktoria Konya; Mirjana Lazarevic; Lisa M Pasterk; Gunther Marsche; Sasa Frank; Bernhard A Peskar; Akos Heinemann; Rufina Schuligoi
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 6.  The therapeutic potential of CRTH2/DP2 beyond allergy and asthma.

Authors:  Katharina Jandl; Akos Heinemann
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-08-14       Impact factor: 3.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.